Dr. Powell’s research focuses on the development of innovative immunotherapeutic strategies, including adoptive immunotherapy using chimeric antigen receptor (CAR) T cells. Dr. Powell will used his ACGT grant to enroll nine, recurrent ovarian cancer patients in a Phase I clinical trial. Immune system killer T cells will be developed outside the body and reinserted to establish an offense against the disease and a defense against recurrence. Dr. Powell’s study seeks to expand on the powerful CAR T immunotherapy study for blood cancers developed by fellow researcher and collaborator, Dr. Carl June.
Return to Fellows List2017-2019 Clinical Investigator